Frequency of anaemia in patients with systemic lupus erythematosus at tertiary care hospitals

Journal of the Pakistan Medical Association

Volumn 60, Issue 10, 2010, Pages 822-825

  Shaikh, Mumtaz Ali ^a   Memon, Iqbal ^a   Ghori, Rafi Ahmed ^a  

^a LUMHS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FERRITIN; FOLIC ACID; IRON; LACTATE DEHYDROGENASE;

ADULT; ANEMIA; ANTIBODY TITER; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CHRONIC DISEASE; CLINICAL ARTICLE; COOMBS TEST; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; FREQUENCY ANALYSIS; HEMOLYTIC ANEMIA; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MACROCYTIC ANEMIA; MALE; MICROCYTIC ANEMIA; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE;

ADULT; ANEMIA; ERYTHROPOIETIN; FEMALE; HOSPITALS, TEACHING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PAKISTAN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77958104348     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hussain N. Lupus. Professional Med J 2008; 51: 179-84.
2. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1- dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008; 9: 378-87.
3. Johnson AE, Gordon C, Bacon PA. The prevalence and incidence of Systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and Country of birth. Arthritis Rheum 1995; 38: 551-8.
4. Hochberg MC. Dubois' Lupus Erythematosus. Wallace DJ, Hahn BH, editors. Baltimore: Williams & Wilkins 1997; pp 49-65.
5. Merrell M, Shulman LE. Determination Of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1955; 1: 12-32.
6. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic Lupus erythematosus: results from a single Center. II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265-70.
7. Gladman DD, Urowitz MB. Prognosis, Mortality and morbidity in systemic lupus Erythematosus. 7th Ed. Philadelphia: Lippincott Williams & Wilkins 2007; pp 1333-53.
8. Mason LJ, Isenberg D. The pathogenesis of systemic lupus erythematosus. Oxford textbook of clinical nephrology. Oxford UK: Oxford University Press 2005; pp 809-29.
9. Reichlin M, Harley JB. Antibodies to Ro/ SSA and La/SSB. Dubois' lupus erythematosus. 6th ed. Philadelphia: Lippincott Williams & Wilkins 2002; pp 467-80.
10. Federman DD. The Biology of Human Sex Differences: N Engl J Med 2006; 354: 1507-14.
11. Hom G, Robert R, et al. Association of Systemic Lupus Erythematosus With c8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 9.
12. Rahman A, Isenberg DA. Systemic Lupus Erythematosus. N Engl J Med 2008; 358: 929-39.
13. Kelly JA, Thompson K, Kilpatrick J, Lam T, Nath SK, Gray-McGuire C, et al. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for SLE families with hemolytic anaemia. Proc Natl Acad Sci USA 2002; 99: 11766-71
14. Remmers EF, Plenge RM, Lec AT, Glaham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and Systemic Lupus Erythematosus. N Engl J Med 2007; 357: 977-86.
15. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin As physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002; 50: 1268-71.
16. Ripley BJ, Goncalves B, Isenberg DA, Latchman DS, Rahman A. Raised levels of interleukin 6 in systemic lupus Erythematosus correlate with anaemia. Ann Rheum Dis 2005; 64: 849-53.
17. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, et al. Gene Copy-Number Variation and Associated Polymorphisms of Complement. Component C4 in Human Systemic Lupus Erythematosus (SLE): Low Copy Number Is a Risk Factor for and High Copy Number Is a Protective Factor against SLE Susceptibility in European Americans. Am J Hum Genet June 2007; 80: 1037-54.
18. Weiss G. Pathogenesis and treatment of Anaemia of chronic disease. Blood Rev 2002; 16: 87-96.
19. Weiss G, Goodnough LT. Anaemia of Chronic Disease. N Engl J Med 2005; 352: 1011-23.
20. Means RT Jr. Recent developments in the anaemia of chronic disease. Curr Hematol Rep 2003; 2: 116-21.
21. Denz H, Huber P, Landmann R, Orth B, Wachter H, Fuchs D. Association between the activation of macrophages, changes of Iron metabolism and the degree of anaemia In patients with malignant disorders. Eur J Haematol 1992; 48: 244-8.
22. Khan AA, Mahmood Q, Khan BA, Bilal N. Frequency and types of anaemia in systemic lupus erythematosus. Ann Pak Inst Med Sci 2006; 2: 272-6.
23. Arbuckle MR, Mcclain MT. Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus. N Engl J Med 2003; 349: 1526-33.
24. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune Hemolytic anaemia and SLE. Am J Med 2000; 108: 198-204.
25. Engelfriet CP, Overbeeke MAM, von dem Borne AEGK. Autoimmune Hemolytic anaemia. Semin Hematol 1992; 29: 3-12.